What Factors Make EU Regulators Want to Communicate Drug Safety Issues Related to SGLT2 Inhibitors? An Online Survey Study

INTRODUCTION: Previous studies have found differences in the communication of safety issues among medicines regulatory agencies. OBJECTIVES: To explore (1) to what extent regulators’ opinions regarding the need to communicate safety issues related to sodium-glucose cotransporter-2 (SGLT2) inhibitors...

Descripción completa

Detalles Bibliográficos
Autores principales: Roldan Munoz, Sonia, Postmus, Douwe, de Vries, Sieta T., Gross-Martirosyan, Liana, Bahri, Priya, Hillege, Hans, Mol, Peter G. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988744/
https://www.ncbi.nlm.nih.gov/pubmed/36790560
http://dx.doi.org/10.1007/s40264-022-01270-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988744/
https://www.ncbi.nlm.nih.gov/pubmed/36790560
http://dx.doi.org/10.1007/s40264-022-01270-4

Ejemplares similares